|
시장보고서
상품코드
1985870
스캐폴드 프리 3D 세포배양 시장 규모, 점유율, 동향 분석 보고서 : 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)Scaffold-free 3D Cell Culture Market Size, Share & Trends Analysis Report By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
스캐폴드 프리 3D 세포배양 시장 요약
세계의 스캐폴드 프리 3D 세포배양 시장 규모는 2025년에 3억 4,490만 달러로 평가되며, 2033년까지 7억 1,080만 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 9.89%로 성장할 전망입니다.
이러한 성장은 신약개발, 재생의료, 맞춤의료에서 첨단 in vitro 모델의 활용 확대, 생체조직을 충실하게 재현하는 세포배양 시스템에 대한 수요에 의해 주도되고 있습니다.
신약개발 활동 증가
제약 및 생명공학 업계에서는 전임상 연구의 질을 향상시키기 위해 스캐폴드 프리 3D 세포배양 시스템의 채택이 확대되고 있습니다. 조직의 구조와 세포 간 상호작용을 충분히 재현할 수 없는 기존 2D 배양과 달리, 스페로이드나 오가노이드와 같은 비계가 필요 없는 모델은 생체내 상태를 보다 충실하게 재현합니다. 이를 통해 약물의 효과와 독성에 대한 보다 정확한 데이터를 얻을 수 있고, 비용이 많이 드는 후기 단계의 실패를 줄일 수 있습니다.
또한 이들 시스템은 대규모 화합물 평가를 위한 자동화 플랫폼 및 이미징 기술과 호환되어 고처리량 신약 스크리닝 및 독성시험을 지원합니다. 환자 유래 3D 모델을 통해 개인별 치료 반응을 검증할 수 있게 되면서 맞춤형 의료의 부상도 도입을 더욱 촉진하고 있습니다. 전체적으로, 비계가 필요 없는 3D 배양은 현대 신약개발의 예측 정확도, 확장성, 적응성을 향상시킵니다.
보다 생리적 관련성이 높은 in vitro 모델의 필요성
기존의 2D 세포배양은 세포 간 상호작용, 형태, 신호전달이 제한되어 생체조직의 복잡성을 재현할 수 없습니다. 구면체나 유기체와 같은 비계가 필요 없는 3차원 시스템에서는 세포가 3차원 공간에서 자기 조직화하므로 조직의 구조와 미세 환경을 보다 충실하게 모방할 수 있습니다. 이를 통해 약물 반응, 독성, 질병 모델링의 예측 정확도가 향상됩니다.
제약 및 생명공학 산업에서 비계가 필요 없는 3D 배양은 번역 연구 분야에서 점점 더 많이 사용되고 있습니다. 이들 모델은 영양분 농도 구배, 산소 확산, 세포 신호전달을 포착할 수 있으며, 환자 유래 오가노이드를 이용한 맞춤형 의료를 지원하고 있습니다. 높은 생물학적 타당성으로 전임상 데이터의 질을 향상시키고, 비용이 많이 드는 후기 단계의 실패를 줄여주기 때문에 전 세계 연구소에서 채택이 증가하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 개요
제3장 시장 변수, 동향, 범위
제4장 스캐폴드 프리 3D 세포배양 시장 : 기술별 비즈니스 분석
제5장 스캐폴드 프리 3D 세포배양 시장 : 용도별 비즈니스 분석
제6장 스캐폴드 프리 3D 세포배양 시장 : 최종 용도별 비즈니스 분석
제7장 스캐폴드 프리 3D 세포배양 시장 : 지역별 추정·동향 분석
제8장 경쟁 구도
KSA 26.04.23Scaffold-free 3D Cell Culture Market Summary
The global scaffold-free 3D cell culture market size was valued at USD 344.9 million in 2025 and is projected to reach USD 710.8 million by 2033, growing at a CAGR of 9.89% between 2026 and 2033. The growth is driven by the rising use of advanced in vitro models for drug discovery, regenerative medicine, personalized healthcare, and demand for cell culture systems that closely mimic native tissues.
Rising Drug Discovery and Development Activities
The pharmaceutical and biotechnology sectors are increasingly using scaffold-free 3D cell culture systems to improve preclinical research. Unlike traditional 2D cultures, which poorly mimic tissue architecture and cellular interactions, scaffold-free models like spheroids and organoids better replicate in vivo conditions, providing more accurate data on drug efficacy and toxicity and reducing costly late-stage failures.
These systems also support high-throughput drug screening and toxicology testing, compatible with automated platforms and imaging technologies for large-scale compound evaluation. The rise of personalized medicine further drives adoption, as patient-derived 3D models enable testing of individualized treatment responses. Overall, scaffold-free 3D culture enhances predictive accuracy, scalability, and adaptability in modern drug discovery.
Need For More Physiologically Relevant In Vitro Models
Traditional 2D cell cultures limit cell interactions, morphology, and signaling, failing to replicate the complexity of living tissues. Scaffold-free 3D systems, like spheroids and organoids, allow cells to self-assemble in three dimensions, better mimicking tissue architecture and microenvironments. This improves predictive accuracy for drug response, toxicity, and disease modeling.
The pharmaceutical and biotechnology sectors are increasingly adopting scaffold-free 3D cultures for translational research. These models capture nutrient gradients, oxygen diffusion, and cell signaling, supporting personalized medicine with patient-derived organoids. Their higher biological relevance enhances preclinical data quality and reduces costly late-stage failures, driving global adoption in research laboratories.
Global Scaffold-free 3D Cell Culture Market Report Segmentation
This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global scaffold-free 3D cell culture market report on the basis of technology, application, end use, and region.
- Technology Outlook (Revenue, USD Million, 2021 - 2033)
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Technology
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Need for more physiologically relevant in vitro models
- 3.2.1.2. Rising drug discovery and development activities
- 3.2.1.3. Growth of personalized medicine and oncology research
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Complexity and Skill Requirements
- 3.2.2.2. Scalability Issues
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
Chapter 4. Scaffold-free 3D Cell Culture Market: Technology Business Analysis
- 4.1. Technology Segment Dashboard
- 4.2. Global Scaffold-free 3D Cell Culture Market Technology Movement Analysis
- 4.3. Global Scaffold-free 3D Cell Culture Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
- 4.4. Hanging Drop Microplates
- 4.4.1. Global Spheroid Microplates with ULA coating Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Spheroid Microplates with ULA coating
- 4.6. Magnetic Levitation
- 4.6.1. Global Magnetic Levitation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Scaffold-free 3D Cell Culture Market: Application Business Analysis
- 5.1. Application Segment Dashboard
- 5.2. Global Scaffold-free 3D Cell Culture Market Application, Movement Analysis
- 5.3. Global Scaffold-free 3D Cell Culture Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Cancer Research
- 5.4.1. Global Cancer Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Stem Cell Research & Tissue Engineering
- 5.5.1. Global Stem Cell Research & Tissue Engineering Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Drug Development & Toxicity Testing
- 5.6.1. Global Drug Development & Toxicity Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Others
- 5.7.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Scaffold-free 3D Cell Culture Market: End Use Business Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Global Scaffold-free 3D Cell Culture Market End Use Movement Analysis
- 6.3. Global Scaffold-free 3D Cell Culture Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Biotechnology & Pharmaceutical Companies
- 6.4.1. Global Biotechnology & Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Academic & Research Institutes
- 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Hospitals
- 6.6.1. Global Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Others
- 6.7.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Scaffold-free 3D Cell Culture Market: Regional Estimates & Trend Analysis by Technology, Application, & End Use.
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
- 7.3. North America
- 7.3.1. North America Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Mexico Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. UK Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Germany Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Australia Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Thailand Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. South Korea Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Argentina Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Saudi Arabia Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. UAE Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait Scaffold-free 3D Cell Culture Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position/Share Analysis, 2025
- 8.4. Participant's Overview
- 8.4.1. Thermo Fisher Scientific Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Merck KGaA
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Corning Incorporated
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Lonza Group AG
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Greiner Bio-One International GmbH
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. InSphero AG
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. REPROCELL Inc.
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Nano3D Biosciences, Inc.
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. PromoCell GmbH
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Tecan Trading AG
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.1. Thermo Fisher Scientific Inc.
